Issued Patents 2021
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11160810 | Fused imidazo-piperidine JAK inhibitor compound | Robert Murray McKinnell, Hao Zhang, Paul R. Fatheree, Lan Jiang, Marta Dabros +1 more | 2021-11-02 |
| 11160800 | Methods of treatment using a JAK inhibitor compound | Hao Zhang | 2021-11-02 |
| 11033533 | (2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid | Melissa Fleury, Adam D. Hughes, Anne-Marie Beausoleil, Erik Fenster, Miroslav Rapta | 2021-06-15 |
| 10968205 | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors | Robert Murray McKinnell, Erik Fenster, Tom M. Lam, Jerry Nzerem, Marta Dabros +1 more | 2021-04-06 |
| 10947254 | Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile | Ryan Hudson, Jennifer Kozak, Dante D. Podesto, Xiaojun Huang | 2021-03-16 |
| 10946009 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Shaoling Li, Manshiu Leung, Hao Zhang, Yun Mo | 2021-03-16 |
| 10913740 | JAK kinase inhibitor compounds for treatment of respiratory disease | Paul R. Fatheree, John R. Jacobsen, Gary E. L. Brandt, Noah Benjamin, Marta Dabros | 2021-02-09 |